Evidence map›Paper›PMID 37407806›Full record

ArticleWorld journal of microbiology & biotechnology2023

In vitro and in silico assessment of anti-quorum sensing activity of Naproxen against Pseudomonas aeruginosa.

Fatemeh Esnaashari, Dorna Rostamnejad, Hossein Zahmatkesh, Hojjatolah Zamani

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Fatemeh EsnaashariDepartment of Biology, Lahijan Branch, Islamic Azad University, Lahijan, Iran.
Dorna RostamnejadDepartment of Microbiology, Lahijan Branch, Islamic Azad University, Lahijan, Iran.
Hossein ZahmatkeshDepartment of Microbiology, Lahijan Branch, Islamic Azad University, Lahijan, Iran.ORCID http://orcid.org/0000-0003-2765-7718
Hojjatolah ZamaniDepartment of Biology, University of Guilan, Rasht, Iran. h_zamani@guilan.ac.ir.ORCID http://orcid.org/0000-0002-1622-4530
Islamic Azad University, Lahijan Branch · IRUniversity of Guilan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serious infections caused by Pseudomonas aeruginosa are usually related to quorum sensing (QS)-dependent virulence factors. Hence, QS inhibition is a promising approach to overcoming P. aeruginosa infections. This study aimed to investigate the effect of naproxen on biofilm formation and QS-related virulence traits of P. aeruginosa. Furthermore, the anti-QS potential of naproxen was evaluated using real-time PCR and molecular docking analysis. Our findings supported the anti-QS activity of naproxen, as evidenced by down-regulation of the lasI and rhlI genes expression as well as the attenuation of bacterial protease, hemolysin, pyocyanin, biofilm, and motility. Additionally, the high binding affinity of naproxen with QS regulatory proteins was determined in the molecular docking simulation. Altogether, these findings suggest that naproxen has a promising potential in inhibiting QS-associated traits of P. aeruginosa.

Indexed as

NaproxenPseudomonas aeruginosaAnti-Bacterial AgentsBacterial ProteinsBiofilmsMolecular Docking SimulationQuorum SensingVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsNaproxenVirulence FactorsAntibiofilmNaproxenPseudomonas aeruginosaQuorum sensing

Identifiers

PMID37407806
OpenAlexW4383303117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.